Market Value3,851,537,802
Total Holdings51
File Date2024-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
VYGR / Voyager Therapeutics, Inc.
MORF / Morphic Holding, Inc.
SLRN / Acelyrin, Inc.
PRME / Prime Medicine, Inc.
ALLO / Allogene Therapeutics, Inc.
GRPH / Graphite Bio, Inc.
NAMS / NewAmsterdam Pharma Company N.V.
RVMD / Revolution Medicines, Inc.
NGM / NGM Biopharmaceuticals, Inc.
GOSS / Gossamer Bio, Inc.
VERV / Verve Therapeutics, Inc.
PHAT / Phathom Pharmaceuticals, Inc.
PRLD / Prelude Therapeutics Incorporated
DCPH / Deciphera Pharmaceuticals, Inc.
TCRX / TScan Therapeutics, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
PRQR / ProQR Therapeutics N.V.
NUVB / Nuvation Bio Inc.
MRSN / Mersana Therapeutics, Inc.
SYRE / Spyre Therapeutics, Inc.
PMVP / PMV Pharmaceuticals, Inc.
XNCR / Xencor, Inc.
JAZZ / Jazz Pharmaceuticals plc
ALGS / Aligos Therapeutics, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
NGNE / Neurogene Inc.
TNGX / Tango Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
RVMD / Revolution Medicines, Inc. Call
ORIC / ORIC Pharmaceuticals, Inc.
ANAB / AnaptysBio, Inc.
HOOK / HOOKIPA Pharma Inc.
TYRA / Tyra Biosciences, Inc.
SWTX / SpringWorks Therapeutics, Inc.
ARVN / Arvinas, Inc.
ZYME / Zymeworks Inc.
NMRA / Neumora Therapeutics, Inc.
PRTA / Prothena Corporation plc
KURA / Kura Oncology, Inc.
EWTX / Edgewise Therapeutics, Inc.
ALLK / Allakos Inc.
CMAXW / CareMax Inc - Warrants (08/06/2026)
ARGX / argenx SE - Depositary Receipt (Common Stock)
ALEC / Alector, Inc.
ITOS / iTeos Therapeutics, Inc.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
SRPT / Sarepta Therapeutics, Inc.
OVID / Ovid Therapeutics Inc.
ATRA / Atara Biotherapeutics, Inc.
TPST / Tempest Therapeutics, Inc.
THRD / Third Harmonic Bio, Inc.
APLS / Apellis Pharmaceuticals, Inc. Call
SRZNW / Surrozen, Inc. - Equity Warrant
RLAY / Relay Therapeutics, Inc.
AVIR / Atea Pharmaceuticals, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
PHVS / Pharvaris N.V.
GBIO / Generation Bio Co.
IMNM / Immunome, Inc.
MRTX / Mirati Therapeutics, Inc.